Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.
Co-morbidities
Co-morbidities
Read time: 19m 41s
Read time: 22m 11s
Video
ESC 24: MRAs in HF
Watch time: 5m 46s
Watch time: 1h 1m 12s
Article
New Insights on HFpEF Treatment
Read time: 18m 10s
Video Series
e-SPACE Cardio-Renal-Metabolic 2024
Broadcast
e-SPACE CRM 2024 - Day 2
Broadcast
e-SPACE CRM 2024 - Day 1
Watch time: 14m 14s
Watch time: 10m 8s
Read time: 5m
Watch time: 1:02:16 (5 videos)
Video Series
SGLT2 inhibition in the comorbid CKD patient
Video Series
e-SPACE CRM 2022
Read time: 10m
Watch time: 6m 48s
Watch time: 1h 34m (7 videos)
Video Series
e-SPACE Cardio-Renal-Metabolic 2023
Broadcast
Hyperkalaemia in Cardiorenal Disease
Watch time: 1h 34m 52s
Video Series
SGLT2 Inhibition in Heart Failure: New Updates
Watch time: 2h 22m (10 videos)
Article
New Insights on HFpEF Treatment
Read time: 18m 10s
Watch time: 1h 1m 12s
About
Media
Watch time: 8m 47s
Watch time: 1h 34m (7 videos)
Video Series
e-SPACE Cardio-Renal-Metabolic 2023
Watch time: 17m 32s
Video Series
SGLT2 Inhibition in Heart Failure: New Updates
Watch time: 2h 22m (10 videos)
Broadcast
e-SPACE CRM 2023 – Day Two
Broadcast
e-SPACE CRM 2023 – Day One
Video Series
HFrEF Patient With Hyperkalaemia
Watch time: 3m 59s (1 video)
Broadcast
Hyperkalaemia in Cardiorenal Disease
Watch time: 1h 34m 52s
Watch time: 1:02:16 (5 videos)
Watch time: 22m 47s
Video Series
e-SPACE CRM 2022
Media
Watch time: 1h 1m 12s
Video Series
e-SPACE CRM 2022
Broadcast
Hyperkalaemia in Cardiorenal Disease
Watch time: 1h 34m 52s
Video Series
SGLT2 inhibition in the comorbid CKD patient
Watch time: 22m 47s
Watch time: 4m 44s
Watch time: 1:02:16 (5 videos)
Watch time: 5m 1s
Watch time: 5m
Video Series
HFrEF Patient With Hyperkalaemia
Watch time: 3m 59s (1 video)
Video Series
SGLT2 Inhibition in Heart Failure: New Updates
Watch time: 2h 22m (10 videos)
Articles
Timing of SGLT2 Inhibitors in Heart Failure
Published:
07 June 2023
Citation:
European Cardiology Review 2023;18:e41.
- Views:
2355
- Downloads:
202
The Predictive Value of NT-proBNP across Glomerular Filtration Rate Subsets in Heart Failure Treated Patients
Published:
25 April 2023
Citation:
European Cardiology Review 2023;18:e18.
- Views:
499
- Downloads:
29
Epicardial Fat in HFpEF: Correlation or Causation?
Published:
15 April 2023
Citation:
Cardiac Failure Review 2023;9:e06.
- Views:
2290
- Downloads:
161
Management of HF in Patients with CKD
Published:
26 July 2022
Citation:
European Cardiology Review 2022;17:e17.
- Views:
15259
- Downloads:
926